Therapeutic, Diagnostic and Prognostic Values of TRIM Proteins in Prostate Cancer

Overview

Journal Pharmacol Rep

Specialty Pharmacology

Date 2023 Nov 3

PMID 37921966

Authors

Xiaojiang Li

Yuzhuo Bai

Ke Feng

Zhendong Chu

Haijun Li

Zhicheng Lin

Lin Tian

Affiliations

Soon will be listed here.

Abstract

Prostate cancer is the second most prevalent cancer in men worldwide. The TRIM (tripartite motif) family of proteins is involved in the regulation of various cellular processes, including antiviral immunity, apoptosis, and cancer progression. In recent years, several TRIM proteins have been found to play important roles in prostate cancer initiation and progression. TRIM proteins have indicated oncogenic activity in prostate cancer by enhancing androgen or estrogen receptor signaling and promoting cancer cell growth. Inhibition of TRIM proteins has been raised as a potential therapeutic strategy for the treatment of prostate cancer. Overall, these studies suggest that TRIM family proteins exert tumor-promoting effects in prostate cancer, and targeting these proteins can provide a promising therapeutic strategy for prostate cancer treatment. On the other hand, some TRIM proteins can be differentially expressed in prostate cancer cells compared to normal cells, thus providing novel diagnostic/prognostic biomarkers for prostate cancer.

Citing Articles

The Role of Pyroptosis in the Progression and Targeted Therapeutic Approaches for Urological Malignancies.

Cheng W, Chen W, Jia R J Inflamm Res. 2024; 17:9567-9581.

PMID: 39606639 PMC: 11600921. DOI: 10.2147/JIR.S487740.

TRIM27 promotes the Warburg effect and glioblastoma progression via inhibiting the LKB1/AMPK/mTOR axis.

Xiao J, Luo H, Gui S, Yu W, Peng L, Huang J Am J Cancer Res. 2024; 14(7):3468-3482.

PMID: 39113875 PMC: 11301283. DOI: 10.62347/TKFV8564.

References

Siegel R, Miller K, Fuchs H, Jemal A . Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1):7-33. DOI: 10.3322/caac.21708. View

Berenguer C, Pereira F, Camara J, Pereira J . Underlying Features of Prostate Cancer-Statistics, Risk Factors, and Emerging Methods for Its Diagnosis. Curr Oncol. 2023; 30(2):2300-2321. PMC: 9955741. DOI: 10.3390/curroncol30020178. View

Hjazi A . The effects of Capsicum annuum supplementation on lipid profiles in adults with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2023; 37(9):3859-3866. DOI: 10.1002/ptr.7922. View

Garg H, Dursun F, Alsayegh F, Wang H, Wu S, Liss M . Revisiting current National Comprehensive Cancer Network (NCCN) high-risk prostate cancer stratification: a National Cancer Database analysis. Prostate Cancer Prostatic Dis. 2023; 27(2):244-251. DOI: 10.1038/s41391-022-00621-7. View

Jochems S, Fritz J, Haggstrom C, Jarvholm B, Stattin P, Stocks T . Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study. Eur Urol. 2022; 83(5):422-431. DOI: 10.1016/j.eururo.2022.03.033. View

Iwasaki M, Itoh H, Sawada N, Tsugane S . Exposure to environmental chemicals and cancer risk: epidemiological evidence from Japanese studies. Genes Environ. 2023; 45(1):10. PMC: 10031963. DOI: 10.1186/s41021-023-00268-3. View

Eiro N, Medina A, Gonzalez L, Fraile M, Palacios A, Escaf S . Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer. Int J Mol Sci. 2023; 24(8). PMC: 10139111. DOI: 10.3390/ijms24087022. View

Kandeel M, Alhumam M, Al-Taher A . Bioinformatics of thymidine metabolism in Trypanosoma evansi: exploring nucleoside deoxyribosyltransferase (NDRT) as a drug target. Trop Biomed. 2021; 38(3):311-317. DOI: 10.47665/tb.38.3.071. View

Khan W, Augustine D, Rao R, Patil S, Awan K, Sowmya S . Lipid metabolism in cancer: A systematic review. J Carcinog. 2021; 20:4. PMC: 8312377. DOI: 10.4103/jcar.JCar_15_20. View

10.

Hamdy F, Donovan J, Athene Lane J, Metcalfe C, Davis M, Turner E . Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med. 2023; 388(17):1547-1558. DOI: 10.1056/NEJMoa2214122. View

11.

Riaz I, Naqvi S, He H, Asghar N, Siddiqi R, Liu H . First-line Systemic Treatment Options for Metastatic Castration-Sensitive Prostate Cancer: A Living Systematic Review and Network Meta-analysis. JAMA Oncol. 2023; 9(5):635-645. PMC: 9982744. DOI: 10.1001/jamaoncol.2022.7762. View

12.

Simeon J, Thrush J, Bailey T . Angiopoietin-like protein 4 is a chromatin-bound protein that enhances mammosphere formation and experimental triple-negative breast cancer brain and liver metastases . J Carcinog. 2021; 20:8. PMC: 8356708. DOI: 10.4103/jcar.JCar_20_20. View

13.

Ocalewski J, Michalska P, Izdebski P, Jankowski M, Zegarski W . Fear of Cancer Progression and Health Behaviors in Patients with Colorectal Cancer. Am J Health Behav. 2021; 45(1):138-151. DOI: 10.5993/AJHB.45.1.11. View

14.

Posdzich P, Darr C, Hilser T, Wahl M, Herrmann K, Hadaschik B . Metastatic Prostate Cancer-A Review of Current Treatment Options and Promising New Approaches. Cancers (Basel). 2023; 15(2). PMC: 9856730. DOI: 10.3390/cancers15020461. View

15.

Cao B, Kim M, Reizine N, Moreira D . Adverse Events and Androgen Receptor Signaling Inhibitors in the Treatment of Prostate Cancer: A Systematic Review and Multivariate Network Meta-analysis. Eur Urol Oncol. 2023; 6(3):237-250. DOI: 10.1016/j.euo.2023.01.001. View

16.

Kartini D, Taher A, Panigoro S, Setiabudy R, Jusman S, Haryana S . Melatonin effect on hypoxia inducible factor-1α and clinical response in patients with oral squamous cell carcinoma receiving neoadjuvant chemotherapy: A randomized controlled trial. J Carcinog. 2021; 20:5. PMC: 8335757. DOI: 10.4103/jcar.JCar_19_20. View

17.

Lin Y, Tan H, Yu G, Zhan M, Xu B . Molecular Mechanisms of Noncoding RNA in the Occurrence of Castration-Resistant Prostate Cancer. Int J Mol Sci. 2023; 24(2). PMC: 9860629. DOI: 10.3390/ijms24021305. View

18.

Tortorella E, Giantulli S, Sciarra A, Silvestri I . AR and PI3K/AKT in Prostate Cancer: A Tale of Two Interconnected Pathways. Int J Mol Sci. 2023; 24(3). PMC: 9917224. DOI: 10.3390/ijms24032046. View

19.

Bai X, Tang J . TRIM proteins in breast cancer: Function and mechanism. Biochem Biophys Res Commun. 2022; 640:26-31. DOI: 10.1016/j.bbrc.2022.11.103. View

20.

Zhan W, Zhang S . TRIM proteins in lung cancer: Mechanisms, biomarkers and therapeutic targets. Life Sci. 2021; 268:118985. DOI: 10.1016/j.lfs.2020.118985. View